Utama › Kanser Prostat › Minnesota › Rochester
Kajian klinikal Kanser Prostat di Rochester, MN
22 kajian untuk Kanser Prostat sedang mencari peserta di lokasi dalam dan sekitar Rochester (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.
Teks kajian rasmi (Bahasa Inggeris)
Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
Mengambil pesertaFasa 2
- Mayo Clinic in Rochester, Rochester
A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation
Mengambil pesertaFasa 3
- Research Site, Rochester
Study of PSMA-targeted Therapy and Androgen Receptor Suppression in Low-volume Metastatic ProstatE Cancer: SPARKLE Trial
Mengambil pesertaFasa 2
- Mayo Clinic in Rochester, Rochester
A Study of GSK5458514 Administered Alone or In Combination With Other Anti-Cancer Agents in Participants With Prostate Cancer
Mengambil pesertaFasa 1/2
- GSK Investigational Site, Rochester
A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
Mengambil pesertaFasa 3
- Mayo Clinic in Rochester, Minnesota-Mayo Clinic Comprehensive Cancer Center ( Site 0078), Rochester
Sacral Neuromodulation for Male Overactive Bladder (MOAB)
Mengambil peserta
- Mayo Clinic, Rochester
Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy
Mengambil pesertaFasa 3
- Mayo Clinic- Rochester, Rochester
FOG-001 in Locally Advanced or Metastatic Solid Tumors
Mengambil pesertaFasa 1/2
- Mayo Clinic, Rochester
Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)
Mengambil pesertaFasa 1
- Mayo Clinic, Rochester
Adaptive Radiation Therapy (ART) Stereotactic Ablative Body Radiotherapy (SABR) for Primary Localized Prostate Cancer
Mengambil peserta
- Mayo Clinic in Rochester, Rochester
MRI-guided Transurethral Urethral Ultrasound Ablation for the Treatment of Low to Intermediate Grade Prostate Cancer
Mengambil peserta
- Mayo Clinic in Rochester, Rochester
Stereotactic Body Radiation Therapy Plus Immediate or Delayed Androgen Receptor Pathway Inhibitor and Androgen Deprivation Therapy or Salvage Radiation Therapy for the Treatment of Prostate Cancer, DIVINE Trial
Mengambil pesertaFasa 2
- Mayo Clinic in Rochester, Rochester
A Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)
Mengambil pesertaFasa 1
- Mayo Clinic, Rochester
Breathing Practice for Brain and Mental Health in Cancer and Neurodegenerative Diseases
Mengambil pesertaSukarelawan sihat dialu-alukan
- Mayo Clinic in Rochester, Rochester
Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Participants With Prostate Cancer
Mengambil pesertaFasa 4
- Mayo Clinic Rochester, Rochester
A Phase I Study of [225Ac]-AZD2284 in Patients With Metastatic Castration-Resistant Prostate Cancer
Mengambil pesertaFasa 1
- Research Site, Rochester
Improvements in Dynamic Contrast-Enhanced MR Angiography and Perfusion and Non-Contrast MRI
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
- Mayo Clinic in Rochester, Rochester
A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
Mengambil pesertaFasa 1/2
- Mayo Clinic, Rochester
Screening and Staging of Benign vs Malignant Pelvic Abnormalities
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
- Mayo Clinic in Rochester, Rochester
cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
- Mayo Clinic, Rochester
Understanding of Genetics by Men at Risk for Prostate Cancer
Mengambil pesertaSukarelawan sihat dialu-alukan
- Mayo Clinic, Rochester
A Phase 1 Study of XL309 (ISM3091) Alone and in Combination in Participants With Advanced Solid Tumors
Mengambil pesertaFasa 1
- Exelixis Clinical Site #14, Rochester
Kajian Kanser Prostat di bandar lain
- New York City, NY103 kajian
- Houston, TX76 kajian
- Los Angeles, CA61 kajian
- Boston, MA59 kajian
- St. Louis, MO46 kajian
- Chicago, IL45 kajian
- San Francisco, CA45 kajian
- Philadelphia, PA44 kajian
- Baltimore, MD43 kajian
- Nashville, TN42 kajian
- Seattle, WA42 kajian
- Washington, DC38 kajian
Kajian lain di Rochester
- Kanser Payudara42 kajian
- Kanser Paru-paru Bukan Sel Kecil37 kajian
- Kanser Metastatik31 kajian
- Kanser (semua jenis)30 kajian
- Kanser Kolorektal29 kajian
- Kanser Ovari29 kajian
- Mieloma Pelbagai24 kajian
- Kegagalan Jantung22 kajian
- Kanser Pankreas22 kajian
- Kanser Paru-paru20 kajian
- Kanser Endometrium20 kajian
- Leukemia Limfositik Kronik19 kajian
Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.